Industry Trends
Novartis to spin-off generics business
Pharma & Medical ProductsNovartis to Spin Off Generics BusinessNovartis to Spin Off Generics Business
The plan is to separate Sandoz, a generics and biosimilars division, to create a standalone company.
Sign up for the Powder & Bulk Solids Weekly newsletter.